Somatic Symptom Disorders in Patients With Myocardial Bridge

NCT ID: NCT04664387

Last Updated: 2022-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1357 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-30

Study Completion Date

2020-05-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to investigate the prevalence of physical and mental disorder in the population of patients with myocardial bridge and to describe the relationship between clinical features and the occurrence of somatic disorder.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Myocardial bridge (MB), a congenital cardiac anomaly, is an unignored contribution to chest pain. Patients with MB often complain about chest discomfort more serious than the degree of vessel compression. The symptoms are also often inconsistence with the degree of coronary stenosis. Reports suggested that patients with MB may companioned with depression and anxiety. Moreover, patients with MB often have other systemic complaints including stomach pain, pain on the back, ear blockage, et al. Investigators assume that somatic symptom disorder (SSD) may play a part in aggregating the severity of symptoms. In order to screen SSD, investigators previously developed the Somatic Symptom Scale-China (SSS-CN) questionnaire. It is a somatic and psychological symptom scale which was developed based on the DSM-5 to assess a combination of psychological, behavioral and somatic symptoms. It is designed to assess the presence and severity of the symptoms. Investigators have validated its reliability and validity in a previous study. The purpose of this study was to investigate the prevalence of physical and mental disorder in the population of patients with MB and to describe the relationship between clinical features and the occurrence of somatic disorder.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Bridge Somatic Symptom Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with myocardial bridge

patients who underwent coronary angiography and was diagnosed as myocardial bridge

coronary angiography

Intervention Type DIAGNOSTIC_TEST

A coronary angiography is a test to find out if there is stenosis in coronary artery.

patients without myocardial bridge

patients who underwent coronary angiography and was diagnosed as without myocardial bridge

coronary angiography

Intervention Type DIAGNOSTIC_TEST

A coronary angiography is a test to find out if there is stenosis in coronary artery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

coronary angiography

A coronary angiography is a test to find out if there is stenosis in coronary artery.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* cardiology inpatients with the age older than 18, complained with chest discomfort and was suspected with coronary artery disease.
* undertook Somatic Symptom Scale-China (SSS-CN) questionnaire, Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires.
* underwent cardiac angiography.
* agree to participate.

Exclusion Criteria

* patients who are in emergency or unconsciousness.
* patients who refuse to participate or with unfinished questionnaire.
* the questionnaires were undertook after the angiography.
* patients who have previously been confirmed to have mental disorders, mental retardation or dementia, cannot finish questionnaires
* patients who currently take anti-anxiety or anti-depression agents.
* patients who have been confirmed to have heart diseases other than coronary vascular disease.
* patients who have been previously confirmed to have other physical diseases.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

RenJi Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Meng Jiang, MD

Role: STUDY_CHAIR

RenJi Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Renji Hospital

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SSSCN202010

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Myocardial Infarction Prediction
NCT01870258 COMPLETED NA